Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Christopher Mallow

7PUBLICATIONS

52CO-AUTHORS

Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Disease surveillanceRespiratory diseasesIberian languages

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 25, 2025

Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Kevin C Ma, Diya Surie, Yuwei Zhu

|Apr 08, 2025

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024.

Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary

|Nov 28, 2024

Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

Nathaniel M Lewis, Elizabeth J Harker, Lauren B Grant

|Oct 15, 2024

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.

David N Hager, Yuwei Zhu, Ine Sohn

|Oct 16, 2023

Association of language concordance and restraint use in adults receiving mechanical ventilation.

Hayley B Gershengorn, Samira Patel, Christopher M Mallow

|Jan 25, 2019

Safety and diagnostic performance of pulmonologists performing electromagnetic guided percutaneous lung biopsy (SPiNperc).

Christopher Mallow, Hans Lee, Catherine Oberg

Pageof 2

Frequent Collaborators

4 joint publications

Wesley H Self

4 joint publications

David N Hager

4 joint publications

Nida Qadir

4 joint publications

Amira Mohamed

4 joint publications

Ithan D Peltan

3 joint publications

Nathaniel M Lewis

3 joint publications

Adam S Lauring

3 joint publications

Kevin W Gibbs

3 joint publications

Manjusha Gaglani

3 joint publications

Yuwei Zhu

Frequent Collaborators

4 joint publications

Wesley H Self

4 joint publications

David N Hager

4 joint publications

Nida Qadir

4 joint publications

Amira Mohamed

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos